Scalper1 News
Big pharma Pfizer missed first-quarter sales estimates Monday but beat on profit and affirmed guidance as analysts focused on the firm’s possible mergers and splits. The stock fell 2.5% to close at 29.98. Pfizer’s (PFE) Q1 earnings totaled 57 cents a share, up 12% from the year-earlier quarter and beating analysts’ consensus by 2 cents. Sales declined 9% to $11.35 billion, missing consensus by about $750 million. The company affirmed its previous Scalper1 News
Scalper1 News